ID: ALA3247541

Max Phase: Preclinical

Molecular Formula: C5H13ClN2O2

Molecular Weight: 132.16

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(N)(CCN)C(=O)O.Cl

Standard InChI:  InChI=1S/C5H12N2O2.ClH/c1-5(7,2-3-6)4(8)9;/h2-3,6-7H2,1H3,(H,8,9);1H

Standard InChI Key:  FMNGXVBRZDFQKX-UHFFFAOYSA-N

Associated Targets(non-human)

Ornithine decarboxylase 167 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 132.16Molecular Weight (Monoisotopic): 132.0899AlogP: -0.86#Rotatable Bonds: 3
Polar Surface Area: 89.34Molecular Species: ZWITTERIONHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.60CX Basic pKa: 10.00CX LogP: -3.59CX LogD: -4.32
Aromatic Rings: 0Heavy Atoms: 9QED Weighted: 0.47Np Likeness Score: 0.92

References

1. Bey P, Danzin C, Van Dorsselaer V, Mamont P, Jung M, Tardif C..  (1978)  Analogues of ornithine as inhibitors of ornithine decarboxylase. New deductions concerning the topography of the enzyme's active site.,  21  (1): [PMID:619149] [10.1021/jm00199a009]

Source